🇬🇧·5h agoRegulatory
Class 4 Medicines Defect Notification: Relonchem Limited, Gabapentin Relonchem 50mg/ml Oral Solution, EL(26)A/31
Publisher
M
MHRA UK
UK
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- MHRA UK
- Region
- UK
- Scope
- Regulatory
- Published
- June 30, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on gov.uk
Leave the platform to read the original full article on the publisher site.
Source: MHRA UK
Scope: Regulatory
Related coverage
More related coverage
openFDA Drug Labels/-529m ago
Drug label update: Evereden Kids Mineral Sunscreen SPF 30
Official structured record identifier: bba219a4-de83-76fd-e053-2995a90a2d69.
openFDA Drug Labels/-529m ago
Drug label update: GUNA-VIRUS
Official structured record identifier: 53e741c4-8897-71f3-e063-6394a90a751d.
ABPI UK/6h ago
Disclosure UK 2025: the 11th year of Disclosure UK data, with industry transparency continuing to grow
ABPI UK/6h ago